Tag: OPT

Opthea ASX OPT positive clinical trial macular degeneration

Opthea achieves positive vision trial, eyes further clinical trials

Biopharmaceutical company Opthea (ASX: OPT) has taken an affirmative step towards commercialising its OPT-302 combination therapy after publishing positive phase 2b clinical trial results...
Opthea ASX OPT diabetic eye disease trial OPT-302

Opthea starts trial for OPT-302 drug in diabetic eye diseases

Biopharmaceutical company Opthea (ASX: OPT) has started a Phase 1b/2a trial investigating the effectiveness of its OPT-302 drug in diabetic eye diseases. Diabetic macular edema...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS